JP Morgan Chase’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,298,822
Closed -$3.95M 7866
2024
Q4
$3.95M Buy
1,298,822
+1,164,641
+868% +$5.07M ﹤0.01% 3578
2024
Q3
$696K Sell
134,181
-2,810,680
-95% -$14M ﹤0.01% 4705
2024
Q2
$7.57M Sell
2,944,861
-208,262
-7% -$711K ﹤0.01% 2700
2024
Q1
$15.5M Sell
3,153,123
-1,490,296
-32% -$8.82M ﹤0.01% 2096
2023
Q4
$40.8M Buy
4,643,419
+13,222
+0.3% +$108K ﹤0.01% 1329
2023
Q3
$53.1M Sell
4,630,197
-63,691
-1% -$1.22M 0.01% 1091
2023
Q2
$119M Sell
4,693,888
-470,269
-9% -$14.6M 0.01% 745
2023
Q1
$166M Buy
5,164,157
+149,735
+3% +$4.67M 0.02% 596
2022
Q4
$92.6M Sell
5,014,422
-436,076
-8% -$9.97M 0.01% 802
2022
Q3
$147M Sell
5,450,498
-1,237,427
-19% -$25.1M 0.02% 584
2022
Q2
$92.4M Sell
6,687,925
-129,280
-2% -$1.99M 0.01% 778
2022
Q1
$133M Sell
6,817,205
-109,201
-2% -$1.66M 0.02% 720
2021
Q4
$113M Buy
6,926,406
+1,844,101
+36% +$30.7M 0.01% 830
2021
Q3
$142M Buy
5,082,305
+38,734
+0.8% +$1.11M 0.02% 702
2021
Q2
$149M Buy
5,043,571
+609,745
+14% +$17.6M 0.02% 714
2021
Q1
$124M Buy
4,433,826
+107,773
+2% +$2.98M 0.02% 755
2020
Q4
$123M Buy
4,326,053
+246,997
+6% +$6.4M 0.02% 706
2020
Q3
$105M Buy
4,079,056
+51,282
+1% +$1.34M 0.02% 679
2020
Q2
$98.4M Buy
4,027,774
+113,176
+3% +$2.23M 0.02% 658
2020
Q1
$57.9M Sell
3,914,598
-109,559
-3% -$2.27M 0.01% 754
2019
Q4
$65.3M Buy
4,024,157
+1,369,385
+52% +$21.2M 0.01% 836
2019
Q3
$34.5M Buy
2,654,772
+179,869
+7% +$2.2M 0.01% 1174
2019
Q2
$31.3M Sell
2,474,903
-1,422,967
-37% -$17.9M 0.01% 1252
2019
Q1
$61.4M Buy
3,897,870
+92,811
+2% +$1.61M 0.01% 867
2018
Q4
$76.6M Buy
3,805,059
+158,448
+4% +$3.49M 0.02% 720
2018
Q3
$90.6M Sell
3,646,611
-18,836
-0.5% -$512K 0.02% 749
2018
Q2
$101M Buy
3,665,447
+228,030
+7% +$6.85M 0.02% 658
2018
Q1
$106M Sell
3,437,417
-120,562
-3% -$3.88M 0.02% 608
2017
Q4
$127M Buy
3,557,979
+11,712
+0.3% +$336K 0.03% 549
2017
Q3
$96.6M Sell
3,546,267
-80,336
-2% -$1.95M 0.02% 640
2017
Q2
$95.7M Buy
3,626,603
+166,759
+5% +$3.72M 0.02% 634
2017
Q1
$72M Buy
3,459,844
+29,686
+0.9% +$610K 0.02% 760
2016
Q4
$71M Buy
3,430,158
+162,457
+5% +$2.72M 0.02% 723
2016
Q3
$53M Sell
3,267,701
-59,321
-2% -$861K 0.01% 799
2016
Q2
$45.2M Buy
3,327,022
+298,448
+10% +$5.28M 0.01% 882
2016
Q1
$52.9M Buy
3,028,574
+94,432
+3% +$1.92M 0.01% 787
2015
Q4
$100M Buy
2,934,142
+1,539,363
+110% +$53.4M 0.03% 558
2015
Q3
$41.5M Sell
1,394,779
-1,726
-0.1% -$52.4K 0.01% 868
2015
Q2
$44.7M Buy
1,396,505
+171,942
+14% +$4.42M 0.01% 938
2015
Q1
$25.4M Buy
1,224,563
+502,287
+70% +$8.68M 0.01% 1272
2014
Q4
$12.2M Sell
722,276
-68,541
-9% -$1.2M ﹤0.01% 1807
2014
Q3
$15.3M Buy
790,817
+115,219
+17% +$3M ﹤0.01% 1619
2014
Q2
$23M Buy
675,598
+406,398
+151% +$12.7M 0.01% 1258
2014
Q1
$8.48M Buy
+269,200
New +$8.41M ﹤0.01% 1805

Other funds holding RVNC